Terms ending in 2043
Every in-force patent on Fondation Imagine's record whose computed term ends in 2043, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,678,491 | Methods for Inducing Full Ablation of Hematopoiesis Inserm (Institut National de la Santé et de la Recherche Médicale), Fondation Imagine, Assistance Publique-Hôpitaux de Paris (Aphp), Université de Paris and Université Toulouse III - Paul Sabatier In force · High confidence | Inserm (Institut National de la Santé et de la Recherche Médicale), Fondation Imagine, Assistance Publique-Hôpitaux de Paris (Aphp), Université de Paris and Université Toulouse III - Paul Sabatier | In force | High confidence | |
| US 12,600,966 | Methods for the Treatment of Retinal Dystrophies by Exon-Skipping Strategy In force · High confidence | Université Paris Cité | In force | High confidence | |
| US 12,590,122 | NRP-1 Binding Inhibitory Peptides and Uses Thereof In force · High confidence | Université Paris Cité | In force | High confidence |
3 of 3 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Fondation Imagine.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.